A bioinformatics analysis reveals that vascular endothelial growth factor A (VEGFA) and its regulatory TF SP2 exert important effects on the development of clear cell sarcoma of the kidney (Wang et al., 2016). This evidence concerns the gene VEGFA and medical procedure.